ArmstrongDGLaveryLA.Monitoring healing of acute Charcot’s arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34(3):317-321.
2.
BariteauJTTenenbaumSRabinovichABrodskyJW.Charcot arthropathy of the foot and ankle in patients with idiopathic neuropathy. Foot Ankle Int. 2014;35(10):996-1001.
3.
BasuSChryssikosTHouseniM. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot’s neuroarthropathy from osteomyelitis and soft-tissue infection?Nucl Med Commun. 2007;28(6):465-472.
4.
BatesMPetrovaNLEdmondsME.How long does it take to progress from cast to shoes in the management of Charcot osteoarthropathy. Diabet Med. 2006;23(suppl 2):27-A100.
5.
BaumhauerJFO’KeefeRJSchonLCPinzurMS.Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study. Foot Ankle Int. 2006;27(10):797-800.
6.
BoyleJPHoneycuttAANarayanKM. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24(11):1936-1940.
7.
BrodskyJ.The diabetic foot. In: MannRACoughlinMJ, eds. Surgery of the Foot and Ankle. 6th ed.St. Louis: Mosby-Year Book; 1993:877-958.
8.
ButtDAHesterTBilalAEdmondsMKavarthapuV.The medial column Synthes Midfoot Fusion Bolt is associated with unacceptable rates of failure in corrective fusion for Charcot deformity: results from a consecutive case series. Bone Joint J. 2015;97-B(6):809-813.
9.
CaravaggiCCimminoMCarusoSDalla NoceS.Intramedullary compressive nail fixation for the treatment of severe Charcot deformity of the ankle and rear foot. J Foot Ankle Surg. 2006;45(1):20-24.
10.
CatanzaritiARMendicinoRHaverstockB.Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000;39(5):291-300.
11.
ChantelauERichterAGhassem-ZadehNPollLW.“Silent” bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases. Arch Orthop Trauma Surg. 2007;127(3):171-177.
12.
ChantelauEAGrutznerG.Is the Eichenholtz classification still valid for the diabetic Charcot foot?Swiss Med Wkly. 2014;144:w13948.
13.
ChantelauEARichterA.The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging—a review of 71 cases. Swiss Med Wkly. 2013;143:w13831.
14.
ChisholmKAGilchristJM.The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13(1):1-13.
15.
ConnorH.Diabetic foot disease—where is the evidence?Diabet Med. 1999;16(10):799-800.
16.
de SouzaLJ. Charcot arthropathy and immobilization in a weight-bearing total contact cast. J Bone Joint Surg Am. 2008;90(4):754-759.
17.
DeVriesJGBerletGCHyerCF.A retrospective comparative analysis of Charcot ankle stabilization using an intramedullary rod with or without application of circular external fixator—utilization of the Retrograde Arthrodesis Intramedullary Nail database. J Foot Ankle Surg. 2012;51(4):420-425.
18.
DhawanVSprattKFPinzurMS. Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int. 2005;26(9):717-731.
19.
EckardtASchollnerCDeckingJ. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Trauma Surg. 2004;124(3):145-150.
20.
EichenholtzSN.Charcot Joints. Springfield, IL: Charles C. Thomas; 1966:7-8.
21.
El-GafaryKAMostafaKMAl-AdlyWY.The management of Charcot joint disease affecting the ankle and foot by arthrodesis controlled by an Ilizarov frame: early results. J Bone Joint Surg Br. 2009;91(10):1322-1325.
22.
EschlerAWussowAUlmarBMittlmeierTGradlG.Intramedullary medial column support with the Midfoot Fusion Bolt (MFB) is not sufficient for osseous healing of arthrodesis in neuroosteoarthropathic feet. Injury. 2014;45(suppl 1):S38-S43.
23.
FarberDCJulianoPJCavanaghPRUlbrechtJCaputoG.Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 2002;23(2):130-134.
24.
FleissDJ.Elevated peak plantar pressures in patients who have Charcot arthropathy (80-A: 365-369, March 1998). J Bone Joint Surg Am. 1998;80(12):1853.
25.
FolestadAAlundMAstebergS. IL-17 cytokines in bone healing of diabetic Charcot arthropathy patients: a prospective 2 year follow-up study. J Foot Ankle Res. 2015;8(1):39.
26.
FolestadAAlundMAstebergS. Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients. J Foot Ankle Res. 2015;8:72.
27.
GameFLCatlowRJonesGR. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55(1):32-35.
28.
GouveriEPapanasN.Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes. 2011;2(5):59-65.
29.
GrantWPGarcia-LavinSSaboR.Beaming the columns for Charcot diabetic foot reconstruction: a retrospective analysis. J Foot Ankle Surg. 2011;50(2):182-189.
30.
GuytonGP.An analysis of iatrogenic complications from the total contact cast. Foot Ankle Int. 2005;26(11):903-907.
31.
HartsellHDFellnerCSaltzmanCL.Pneumatic bracing and total contact casting have equivocal effects on plantar pressure relief. Foot Ankle Int. 2001;22(6):502-506.
32.
HastingsMKJohnsonJEStrubeMJ. Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am. 2013;95(13):1206-1213.
33.
HerbstSAJonesKBSaltzmanCL.Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004;86(3):378-383.
34.
HocheGSandersLJ.On some arthropathies apparently related to a lesion of the brain or spinal cord, by Dr J.-M. Charcot. January 1868. J Am Podiatr Med Assoc. 1992;82(8):403-411.
35.
HockenburyRTGruttadauriaMMcKinneyI.Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int. 2007;28(9):971-976.
36.
HolsteinPLohmannMBitschMJorgensenB.Achilles tendon lengthening, the panacea for plantar forefoot ulceration?Diabetes Metab Res Rev. 2004;20(suppl 1):S37-S40.
37.
JeffcoateWJGameFCavanaghPR.The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366(9502):2058-2061.
38.
JohnsonJT.Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am. 1967;49(1):1-30.
39.
JudeEBSelbyPLBurgessJ. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032-2037.
MorganJMBiehlWC3rdWagnerFWJr.Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop Relat Res. 1993;296:58-63.
47.
MuellerMJSinacoreDRHastingsMKStrubeMJJohnsonJE.Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am. 2003;85-A(8):1436-1445.
48.
NdipAWilliamsAJudeEB. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60(8):2187-2196.
49.
PakarinenTKLaineHJMaenpaaHMattilaPLahtelaJ.The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial. Diabetes Care. 2011;34(7):1514-1516.
50.
PalestroCJLoveC.Nuclear medicine and diabetic foot infections. Semin Nucl Med. 2009;39(1):52-65.
51.
PalestroCJMehtaHHPatelM. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998;39(2):346-350.
52.
PetrovaNLDewTKMustoRL. Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy. Diabet Med. 2015;32(2):267-273.
53.
PinzurM.Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25(8):545-549.
54.
PinzurMS.Neutral ring fixation for high-risk nonplantigrade Charcot midfoot deformity. Foot Ankle Int. 2007;28(9):961-966.
55.
PinzurMSEvansA.Health-related quality of life in patients with Charcot foot. Am J Orthop (Belle Mead NJ). 2003;32(10):492-496.
56.
PinzurMSKelikianA.Charcot ankle fusion with a retrograde locked intramedullary nail. Foot Ankle Int. 1997;18(11):699-704.
57.
PinzurMSLioTPosnerM.Treatment of Eichenholtz stage I Charcot foot arthropathy with a weightbearing total contact cast. Foot Ankle Int. 2006;27(5):324-329.
58.
PitoccoDRuotoloVCaputoS. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28(5):1214-1215.
59.
RajbhandariSMJenkinsRCDaviesCTesfayeS.Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085-1096.
60.
RichterMMittlmeierTRammeltS. Intramedullary fixation in severe Charcot osteo-neuroarthropathy with foot deformity results in adequate correction without loss of correction—results from a multi-centre study. Foot Ankle Surg. 2015;21(4):269-276.
61.
RogersLCBevilacquaNJ.The diagnosis of Charcot foot. Clin Podiatr Med Surg. 2008;25(1):43-51, vi.
62.
RogersLCFrykbergRGArmstrongDG. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129.
63.
RosenblumBIGiuriniJMMillerLBChrzanJSHabershawGM.Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg. 1997;36(5):360-363.
64.
SaltzmanCLHagyMLZimmermanBEstinMCooperR.How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?Clin Orthop Relat Res. 2005;435:185-190.
65.
SammarcoVJSammarcoGJWalkerEWJrGuiaoRP.Midtarsal arthrodesis in the treatment of Charcot midfoot arthropathy. J Bone Joint Surg Am. 2009;91(1):80-91.
66.
SandersLJFrykbergRG.Diabetic neuropathic osteoarthropathy: the Charcot foot. In: FrykbergRG, ed. The High Risk Foot in Diabetes Mellitus. New York: Churchill Livingstone; 1991:297-338.
67.
SandersLJFrykbergRG.The Charcot Foot (Pied de Charcot). In: LevinMEBowerJHPfeiferMA, eds. Levin’s and O’Neal’s The Diabetic Foot. 7th ed.Philadelphia: Mosby Elsevier; 2007:257-283.
68.
SchaperNCHuijbertsMPickwellK.Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab Res Rev. 2008;24(suppl 1):S40-S44.
69.
SchootsIGSlimFJBusch-WestbroekTEMaasM.Neuro-osteoarthropathy of the foot-radiologist: friend or foe?Semin Musculoskelet Radiol. 2010;14(3):365-376.
70.
SeaboldJEFlickingerFWKaoSC. Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31(5):549-556.
71.
ShagosGSShanmugasundaramPVarmaAKPadmaSSarmaM.18-F flourodeoxy glucose positron emission tomography-computed tomography imaging: a viable alternative to three phase bone scan in evaluating diabetic foot complications?Indian J Nucl Med. 2015;30(2):97-103.
72.
ShapiroSAStansberryKBHillMA. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complications. 1998;12(3):147-153.
73.
ShibataTTadaKHashizumeC.The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am. 1990;72(5):749-756.
74.
SiebachmeyerMBodduKBilalA. Outcome of one-stage correction of deformities of the ankle and hindfoot and fusion in Charcot neuroarthropathy using a retrograde intramedullary hindfoot arthrodesis nail. Bone Joint J. 2015;97-B(1):76-82.
75.
SimonSRTejwaniSGWilsonDLSantnerTJDennistonNL.Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82-A(7):939-950.
76.
ToledanoTRFatoneEAWeisACottenABeltranJ.MRI evaluation of bone marrow changes in the diabetic foot: a practical approach. Semin Musculoskelet Radiol. 2011;15(3):257-268.
77.
VarshneyGCHenryJKahnAPhan-Dinh-TuyF.Tyrosine kinases in normal human blood cells. Platelet but not erythrocyte band 3 tyrosine kinase is p60c-src. FEBS Lett. 1986;205(1):97-103.
78.
VeritySSochockiMEmbilJMTrepmanE.Treatment of Charcot foot and ankle with a prefabricated removable walker brace and custom insole. Foot Ankle Surg. 2008;14(1):26-31.
79.
WiewiorskiMYasuiTMiskaMFriggAValderrabanoV.Solid bolt fixation of the medial column in Charcot midfoot arthropathy. J Foot Ankle Surg. 2013;52(1):88-94.
